NCT06479577 US & HILT Comparative Effect on Neuropathic Pain, Strength & QOF in Diabetic Foot
| NCT ID | NCT06479577 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Diabetic Foot |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2024-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2024-02-01 with a primary completion date of 2024-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the effects of therapeutic ultrasound and high intensity laser therapy on neuropathic pain , strength and quality of life in patients with diabetic foot
Eligibility Criteria
Inclusion Criteria: * Patients with type 2 diabetes. * Diabetic Patients of age 50 to 75 years. * Diabetic patient of Both genders * Diagnosed Diabetes Mellitus with at least 7 years of duration * Distal symmetrical or asymmetrical polyneuropathy with pain in the lower extremity for ≥6 months * DNS (Diabetic neuropathy symptoms questionnaire) score greater than 4 (90 percent probability of neuropath Exclusion Criteria: * Pregnant females * Lower limb Amputated patients * History or evidence of neurological disorders other than peripheral neuropathy associated with Diabetes mellitus. * Evidence of musculoskeletal dysfunctions like scoliosis, lumbar disc prolapses and lumbar spine associated radiculopathy. * History of any low back surgeries and lower limb surgeries * Patient with malignancy. Patient with epilepsy * Patient with hemophilia * Patient with pacemaker, metal implants prosthesis and internal fixation screws. * Patient with severe cervical and lumbar neuropathy, rheumatoid arthritis, hereditary neuropathy * Patient with a history of neurosurgery
Contact & Investigator
Aruba Saeed, Phd
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06479577 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 75 Years, studying Diabetic Foot. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06479577 currently recruiting?
Yes, NCT06479577 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06479577 trial being conducted?
This trial is being conducted at Bahawalpur, Pakistan.
Who is sponsoring the NCT06479577 clinical trial?
NCT06479577 is sponsored by Riphah International University. The principal investigator is Aruba Saeed, Phd at Riphah International University. The trial plans to enroll 46 participants.